MedTrace Logo

Efficacy & Safety of Pedyphar Ointment in Diabetic Foot Ulcer Treatment

NCT02379468 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-03-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of Pedyphar® ointment in the healing of foot ulceration in diabetic patients.

Conditions

  • Diabetic Foot Ulcer

Interventions

DRUG

Pedyphar Ointment

DRUG

Panthenol

Ointment

Sponsors & Collaborators

  • European Egyptian Pharmaceutical Industries

    lead INDUSTRY

Principal Investigators

  • Samir H. Asaad, Prof. · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-08-31
Completion
2014-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02379468 on ClinicalTrials.gov